Nature Reviews Clinical Oncology
Disseminated breast tumour cells: biological and clinical meaning | Nature Reviews Clinical Oncology
Progress in refining the clinical management of cancer of unknown primary in the molecular era | Nature Reviews Clinical Oncology
Volume 18 | Nature Reviews Clinical Oncology
Volume 17 | Nature Reviews Clinical Oncology
Volume 13 | Nature Reviews Clinical Oncology
Tumour heterogeneity and resistance to cancer therapies | Nature Reviews Clinical Oncology
Driving CAR T-cells forward | Nature Reviews Clinical Oncology
Volume 17 | Nature Reviews Clinical Oncology
Chimeric antigen receptor T-cell therapies for lymphoma | Nature Reviews Clinical Oncology
Work featured in Nature Reviews Clinical Oncology | Gevaert Lab | Stanford Medicine
Clinical overview of metronomic chemotherapy in breast cancer | Nature Reviews Clinical Oncology
Volume 16 | Nature Reviews Clinical Oncology
Computational oncology — mathematical modelling of drug regimens for precision medicine | Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? | Nature Reviews Clinical Oncology
Immuno-oncology drug development goes global
Article Series: Nature Reviews Clinical Oncology
Volume 8 | Nature Reviews Clinical Oncology
Volume 15 | Nature Reviews Clinical Oncology
Imaging biomarker roadmap for cancer studies | Nature Reviews Clinical Oncology
Volume 14 | Nature Reviews Clinical Oncology
COVID-19 in clinical oncology
Can oncology recapitulate paleontology? Lessons from species extinctions | Nature Reviews Clinical Oncology
